Comments

Summit Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SMMTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$19.75

0.311.59%

At close: -

$19.85

0.100.51%

After Hours: Mar 21, 7:36 PM EDT

Summit Therapeutics (SMMT) Forecast

News Earnings Summit Therapeutics (SMMT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Summit Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SMMT | Benzinga

Explore Summit Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SMMT.

Open	$19.44
Close	$19.75
Volume / Avg.	3.30M / 2.47M
Day Range	$19.13 - $20.02
52 Wk Range	2.10 - 33.89
Market Cap	$14.64B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	18.17%
Days to Cover	6.98

Recent News

Applovin, Super Micro Computer And Intel Among Top 10 Large-Cap Gainers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?

Top 10 large-cap stocks rose last week: Rubrik 23.17%, Applovin 17.21%, Summit Therapeutics 16.93%, Intel 16.52%, VG 16.03%, GE Vernova 14.01%, Samsara 11.96%, Antero Resources 11.68%, Super Micro 10.28%, ConocoPhillips 9.18%

Lekha Gupta

This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday?

The major indices struggled to maintain early momentum on Monday, but appear to climbing back with the S&P 500 and Dow Jones both green in midday trading.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.44
Close	$19.75
Volume / Avg.	3.30M / 2.47M
Day Range	$19.13 - $20.02
52 Wk Range	2.10 - 33.89
Market Cap	$14.64B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	18.17%
Days to Cover	6.98

About Summit Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Summit Therapeutics (SMMT) stock?

You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.

View our list of the best stock brokerages

Who are Summit Therapeutics (SMMT) competitors?

Other companies in Summit Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?

Summit Therapeutics has a consensus price target of $33.90.

What is the current price for Summit Therapeutics (SMMT)?

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $19.85 last updated March 21, 2025 at 7:36 PM EDT.

Does Summit Therapeutics (SMMT) pay a dividend?

There are no upcoming dividends for Summit Therapeutics.

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

Summit Therapeutics’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Summit Therapeutics (SMMT) going to split?

There is no upcoming split for Summit Therapeutics.

What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.